Clinical trials
Terminated Multiple Myeloma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| AbbVie | 3 |
| Celgene | 3 |
| Amgen | 2 |
| Anaveon AG | 1 |
| Dr. med. Lars-Olof Muegge | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 28 |
| Recurrence | 8 |
| Neoplasms | 4 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
| Myelodysplastic Syndromes | 2 |
| Myeloproliferative Disorders | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Blast Crisis | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.